---
input_text: 'Canavan disease: studies on the knockout mouse. Canavan disease (CD)
  is an autosomal recessive disorder, characterized by spongy degeneration of the
  brain. Patients with CD have aspartoacylase (ASPA) deficiency, which results accumulation
  of N-acetylaspartic acid (NAA) in the brain and elevated excretion of urinary NAA.
  Clinically, patients with CD have macrocephaly, mental retardation and hypotonia.
  A knockout mouse for CD which was engineered, also has ASPA deficiency and elevated
  NAA. Molecular studies of the mouse brain showed abnormal expression of multiple
  genes in addition to ASPA deficiency. Adenoassociated virus mediated gene transfer
  and stem cell therapy in the knockout mouse are the latest attempts to alter pathophysiology
  in the CD mouse.'
raw_completion_output: |-
  primary_disease: Canavan disease

  medical_actions: Adenoassociated virus mediated gene transfer; Stem cell therapy

  symptoms: Spongy degeneration of the brain; Macrocephaly; Mental retardation; Hypotonia

  chemicals: N-acetylaspartic acid

  action_annotation_relationships: Adenoassociated virus mediated gene transfer TREATS spongy degeneration of the brain IN Canavan disease; Stem cell therapy TREATS spongy degeneration of the brain IN Canavan disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Stem cell therapy TREATS spongy degeneration of the brain IN Canavan disease

  ===

extracted_object:
  primary_disease: MONDO:0010079
  medical_actions:
    - Adenoassociated virus mediated gene transfer
    - Stem cell therapy
  symptoms:
    - Spongy degeneration of the brain
    - HP:0000256
    - HP:0001249
    - HP:0001252
  chemicals:
    - CHEBI:21547
  action_annotation_relationships:
    - subject: Gene transfer
      predicate: TREATS
      object: Spongy degeneration of the brain
      qualifier: MONDO:0010079
      subject_extension: Adenoassociated virus mediated gene transfer
    - subject: Stem cell therapy
      predicate: TREATS
      object: spongy degeneration of the brain
      qualifier: MONDO:0010079
named_entities:
  - id: MONDO:0010079
    label: Canavan disease
  - id: MONDO:0003847
    label: Genetic disorders
  - id: HP:0000739
    label: Anxiety
  - id: HP:0001251
    label: ataxia
  - id: CHEBI:16953
    label: N-acetyl-L-aspartate
  - id: CHEBI:76720
    label: antisense oligonucleotide
  - id: MONDO:0019052
    label: Inborn errors of metabolism (IEM)
  - id: CHEBI:35584
    label: Purines
  - id: CHEBI:16898
    label: Pyrimidines
  - id: CHEBI:35692
    label: Dicarboxylic acids
  - id: CHEBI:16040
    label: Cytosine
  - id: CHEBI:17562
    label: Cytidine
  - id: CHEBI:16737
    label: Creatinine
  - id: CHEBI:17568
    label: Uracil
  - id: CHEBI:16704
    label: Uridine
  - id: CHEBI:17802
    label: Beta-pseudouridine
  - id: CHEBI:16708
    label: Adenine
  - id: CHEBI:38635
    label: 3-methyladenine
  - id: CHEBI:17368
    label: Hypoxanthine
  - id: CHEBI:15318
    label: Xanthine
  - id: CHEBI:18107
    label: Xanthosine
  - id: CHEBI:17596
    label: Inosine
  - id: CHEBI:16750
    label: Guanosine
  - id: CHEBI:22652
    label: Ascorbic acid
  - id: CHEBI:17821
    label: Thymine
  - id: CHEBI:17748
    label: Thymidine
  - id: CHEBI:27226
    label: Uric acid
  - id: CHEBI:68441
    label: 1-methyluric acid
  - id: CHEBI:16742
    label: Orotic acid
  - id: CHEBI:76931
    label: N-acetylaspartylglutamate
  - id: CHEBI:30794
    label: Malonic acid
  - id: CHEBI:30860
    label: Methylmalonic acid
  - id: CHEBI:16856
    label: GSH
  - id: CHEBI:17858
    label: GSSG
  - id: CHEBI:30145
    label: lithium
  - id: MONDO:0019046
    label: leukodystrophies
  - id: MAXO:0000127
    label: genetic testing
  - id: MAXO:0009004
    label: whole exome sequencing (WES)
  - id: MAXO:0000079
    label: genetic counseling
  - id: HP:0000256
    label: Macrocephaly
  - id: HP:0001249
    label: Mental retardation
  - id: HP:0001252
    label: Hypotonia
  - id: CHEBI:21547
    label: N-acetylaspartic acid
